Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
11/04/2008 | CA2274244C Methods for diagnosing glaucoma and discovering anti-glaucoma drugs |
11/04/2008 | CA2112998C Polyphenol oxidase genes |
11/02/2008 | CA2630701A1 Kit and method to perform a biological test designed to evaluate minerals potential for being bioleached |
10/30/2008 | WO2008131445A1 Device and method for transfecting cells for therapeutic use |
10/30/2008 | WO2008131441A1 Methods and compositions involving ltas |
10/30/2008 | WO2008131382A2 Drop-on-demand manufacturing of diagnostic test strips |
10/30/2008 | WO2008131376A2 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
10/30/2008 | WO2008131324A1 A method for determining insulin sensitivity and glucose absorption |
10/30/2008 | WO2008131314A1 Method for employing a biosensor to detect small molecules that bind directly to immobilized targets |
10/30/2008 | WO2008131274A2 Workpiece stabilizing device |
10/30/2008 | WO2008131261A2 Peptide biomarkers of cardiovascular disease |
10/30/2008 | WO2008131251A1 Wet gas measurement |
10/30/2008 | WO2008131224A2 Diabetes-related biomarkers and methods of use thereof |
10/30/2008 | WO2008131216A1 Hapten compounds and compositions and uses thereof |
10/30/2008 | WO2008131094A1 Method for controlling glucose uptake and insulin sensitivity |
10/30/2008 | WO2008131063A1 Methods of use of solid support material for binding biomolecules |
10/30/2008 | WO2008131048A2 Devices and methods for diagnosing, prognosing, or theranosing a condition by enriching rare cells |
10/30/2008 | WO2008131047A2 Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism |
10/30/2008 | WO2008131039A2 Cardibioindex/cardibioscore and utility of salivary proteome in cardiovascular diagnostics |
10/30/2008 | WO2008131035A2 Methods for diagnosing, prognosing, or theranosing a condition using rare cells |
10/30/2008 | WO2008130926A2 Characterization of n-glycans using exoglycosidases |
10/30/2008 | WO2008130920A1 Biosensor and methods of reagent patterning for a multiple well biosensor |
10/30/2008 | WO2008130910A1 Detection her-2/neu protein from non-isolated circulating cancer cells and treatment |
10/30/2008 | WO2008130887A1 Biomarkers for follicular thyroid carcinoma and methods of of use |
10/30/2008 | WO2008130686A1 Apo b measurement system and method |
10/30/2008 | WO2008130680A1 Analytical devices with intedrated desiccant |
10/30/2008 | WO2008130655A1 Methods for counting cells |
10/30/2008 | WO2008130614A2 Selective and dual-action p53/mdm2/mdm4 antagonists |
10/30/2008 | WO2008130516A1 Epigenetic biomarkers for early detection, therapeutic effectiveness, and relapse monitoring of cancer |
10/30/2008 | WO2008130488A1 Live-cell signals of pathogen intrusion and methods thereof |
10/30/2008 | WO2008130463A2 Multiplexed nanoscale electrochemical sensors for multi-analyte detection |
10/30/2008 | WO2008130432A2 Nanoscale spintronic chemical sensor |
10/30/2008 | WO2008130429A2 Detecting nitric oxide |
10/30/2008 | WO2008130416A1 Method and system for preparing a blood sample for a disease association gene transcript test |
10/30/2008 | WO2008130327A1 Biointerfaces for biomolecule detection |
10/30/2008 | WO2008130263A1 Monomer and composition for producing low-percentage hydrogel and/or hydrogel having a low cross linkage content, a hydrogel and a biochip based thereon |
10/30/2008 | WO2008130053A1 Fused protein comprising protein g with avidin |
10/30/2008 | WO2008130034A1 Polyamino acid synthetase and gene encoding the same |
10/30/2008 | WO2008129928A1 Biomolecule labeling reagent, and biomolecule detection system using the same |
10/30/2008 | WO2008129896A1 Method of diagnosing asthenospermia |
10/30/2008 | WO2008129682A1 Method of testing prevention of metallic soap adhesion |
10/30/2008 | WO2008129419A2 Method for detecting and/or isolating mycobacteria |
10/30/2008 | WO2008129302A1 Assav devices and methods and components for use therein |
10/30/2008 | WO2008129296A2 Disease markers |
10/30/2008 | WO2008129265A1 Diagnostics and therapeutics for diabetic nephropathy involving ccl18 |
10/30/2008 | WO2008128730A2 Antagonists of bitter taste receptors and uses thereof |
10/30/2008 | WO2008128679A1 Polypeptide as standard for proteome analysis |
10/30/2008 | WO2008128559A1 Method for providing a compound capable of interfering with a distorted chondrocyte phenotype |
10/30/2008 | WO2008128455A1 Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereof |
10/30/2008 | WO2008128399A1 Device for washing and hybridization of biochips |
10/30/2008 | WO2008128363A1 Device and method for the capacitive analysis of a moving elongate test material |
10/30/2008 | WO2008128352A1 Methods and compositions for signal amplification |
10/30/2008 | WO2008128333A1 A method to distinguish antibody-mediated tissue rejection from t cell-mediated tissue rejection |
10/30/2008 | WO2008128299A1 Therapeutic protocol for treating hemoglobinopathy |
10/30/2008 | WO2008109659A3 Complexes of hyaluronans, other matrix components, hormones and growth factors for maintenance, expansion and/or differentiation of cells |
10/30/2008 | WO2008109332A3 Methods and compositions for determining the efficacy of breast cancer therapeutics |
10/30/2008 | WO2008109030A3 Methods and compositions for identifying prostate cancer or a humoral immune response against prostate cancer |
10/30/2008 | WO2008108803A9 Immune cell biosensors and methods of using same |
10/30/2008 | WO2008104062A3 Selective release of pro-apoptotic bcl-2 family members and their contribution to the bystander effect |
10/30/2008 | WO2008103471A3 Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease |
10/30/2008 | WO2008103327A3 Mn/ca ix and bladder cancer |
10/30/2008 | WO2008099280A3 Regulation of expression of pi3kb protein in tumors |
10/30/2008 | WO2008098995A9 Genes involved in mitochondrial biogenesis |
10/30/2008 | WO2008096318A3 Identification system |
10/30/2008 | WO2008095905A3 Pathogen binding |
10/30/2008 | WO2008084403A3 Method and apparatus for the identification of persons based on the analysis of volatile substances of said persons in the surrounding gas |
10/30/2008 | WO2008082710A3 A method of surface plasmon resonance (spr) technology to detect genomic aberrations in patients with multiple myeloma |
10/30/2008 | WO2008074329A3 Modulation of activity of proneurotrophins |
10/30/2008 | WO2008070385A3 Uses of a murine model of hiv-1 infection |
10/30/2008 | WO2008064291A3 Intermediates and methods for forming passivated surfaces on oxide layers and articles produced thereby |
10/30/2008 | WO2008063521A3 Gene-based clinical scoring system |
10/30/2008 | WO2008062314A3 Circulating ve-cadherin as a predictive marker of sensitivity or resistance to anti-tumoral treatment, and improved method for the detection of soluble proteins. |
10/30/2008 | WO2008061149A3 Methods and compositions for diagnosis and prognosis of renal artery stenosis |
10/30/2008 | WO2008060489A3 Stable cell lines and methods for evaluating gastrointestinal absorption of chemicals |
10/30/2008 | WO2008057233A3 Models of erythropoiesis |
10/30/2008 | WO2008054724A3 Monoclonal antibodies against osteopontin |
10/30/2008 | WO2008041849A3 Methods and means for determining satiety on saliva |
10/30/2008 | WO2008039772A3 Polymerase variants for dna sequencing |
10/30/2008 | WO2008036239A3 Use of lxr agonists for the treatment of osteoarthritis |
10/30/2008 | WO2008033435A3 Detachable test sensor container having a system for reducing coding errors |
10/30/2008 | WO2008030986A3 Molecular diagnosis and classification of malignant melanoma |
10/30/2008 | WO2008030548A3 Voltage-sensitive fret assay employing pyrene trisulfonic donor |
10/30/2008 | WO2008030290A3 Novel dairy herd management methods |
10/30/2008 | WO2008024832A3 Methods for isolating and using pituitary adenoma stem cells and pituitary adenoma cells |
10/30/2008 | WO2008022278A3 Atypical pkc mediates wnt signaling in growth cone guidance |
10/30/2008 | WO2008022177A3 Methods for diagnosing irritable bowel syndrome |
10/30/2008 | WO2008022036A3 Method and apparatus for protein sequence alignment using fpga devices |
10/30/2008 | WO2008014050A3 Assays based on light emission from analyte complexes within a cassette |
10/30/2008 | WO2008009004A3 Reagents for the detection of protein phosphorylation in signaling pathways |
10/30/2008 | WO2007131210A3 T-cell vaccine |
10/30/2008 | WO2007131031A3 Diagnosis of pulmonary and/or cardiovascular disease |
10/30/2008 | WO2007130831A3 Methods and apparatus for identifying disease status using biomarkers |
10/30/2008 | WO2007120815A3 Methods for treating lymphocyte-associated disorders by modulation of siglec activity |
10/30/2008 | WO2007115095A3 Systems and methods for using molecular networks in genetic linkage analysis of complex traits |
10/30/2008 | WO2007109881A9 Biomarkers useful for diagnosing prostate cancer, and methods thereof |
10/30/2008 | WO2007109307A3 Antibodies directed to angiopoietin-like protein 4 and uses thereof |
10/30/2008 | WO2007100782A8 Biomarkers for amyotrophic lateral sclerosis and methods using the same |
10/30/2008 | WO2007095186A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer |
10/30/2008 | WO2007074193A3 Method for the analysis of differential expression in colorectal cancer |
10/30/2008 | WO2007017768A3 Novel uses for drugs targeting glutamine synthetase |